行业观察

Microsoft reviews AI startup deals as it builds in-house AI models.The internal AI moves come as OpenAI agreement changes.Microsoft is assessing potential acquisitions of artificial intelligence start

And another massive week for legal AI! But first, let’s hear it for our amazing Legal Innovators California sponsors. Below are many of the legal tech companies, ALSPs, and other businesses taking par

By Sabrina Pervez, SpotDraft. Recent years have witnessed several legal tech M&A deals. DocuSign bought Lexion to add AI to its IAM platform. Workday’s CLM exists because of the Evisort acquisition. L

Health tracker consumer brand WHOOP expands its offerings.Users can opt for clinician consultations with WHOOP-derived information.Line between consumer and clinical data prompts data-sharing concerns

Copy link Facebook X Whatsapp Reddit Pinterest Flipboard Threads Email Share this article 0 Join the conversation Follow us Add us as a preferred source on Google Newsletter Subscribe to our newslette

Copy link Facebook X Whatsapp Reddit Pinterest Flipboard Threads Email Share this article 0 Join the conversation Follow us Add us as a preferred source on Google Newsletter Subscribe to our newslette

Copy link Facebook X Whatsapp Reddit Pinterest Flipboard Threads Email Share this article 0 Join the conversation Follow us Add us as a preferred source on Google Newsletter Subscribe to our newslette

Some people are trying to emulate AI by thinking as AI thinks.gettyIn today’s column, I examine a newly emerging trend involving people opting to change how they think by emulating the way that AI thi

The Claude by Anthropic app logo appears on the screen of a smartphone in Reno, United States, on November 21, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)NurPhoto via Getty ImagesOn Tuesday

ジャパンディスプレイ（JDI）は2026年5月14日、2025年度通期の決算を発表した。売上高は前年比29.6％減の1323億円で、営業損失は同184億円改善し187億円だった。純損失は同584億円改善し198億円だった。 2025年度通期のJDIの業績概要［クリックで拡大］ 出所：ジャパンディスプレイ 売上高の減少には、ディスプレイ事業の戦略的縮小を進めてきたことや、民生／産業機器鳥取工場（鳥取

2026年5月14日——达歌生物（Degron Therapeutics，简称“达歌”），一家致力于开发分子胶降解剂药物的临床阶段生物技术公司，今日宣布完成4,000万美元A轮扩展融资。本轮融资由龙磐资本领投，高特佳投资、达晨财智、石药国方先导基金、一品红、广发信德、金阖资本及弘业基金等机构共同参与。在达歌生物的A轮融资中，BV百度风投参与投资，成为长期伙伴。本轮融资完成后，达歌累计融资额达到9,

5月14日，百济神州宣布，其索托克拉（商品名：BEQALZI™，百悦达®）获得美国 FDA 加速批准，用于治疗既往接受过至少两线系统治疗（含布鲁顿酪氨酸激酶[BTK]抑制剂）的复发或难治性（R/R）套细胞淋巴瘤（MCL）成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改

Varda Space Industries announced a collaboration with United Therapeutics Corporation to explore the use of microgravity to develop improved formulations of treatments for rare pulmonary disease. Thro

Voyager Technologies and Exobiosphere announced a mission management contract on the International Space Station (ISS) that marks a concrete step toward making automated biological research in microgr

The commercial space industry is entering a new phase. The era of launch vehicles is maturing, satellite constellations are scaling and attention is shifting toward the infrastructure, data, logistics